oncology

Special Report

New Approved Treatments and Indications in Oncology

12/29/2020

Journal of Clinical Pathways

Research Reports

Use of Clinical Decision Support and Peer Review to Increase NCCN Guideline Adherence

02/18/2020

Margaret Rausa, PharmD

David Spangler

Stephen Hamilton, MD

Eric Gratias, MD, FAAP

Abstract: eviCore healthcare uses the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®) to support its proprietary program for medical oncology drug management. The...

...

02/18/2020

Journal of Clinical Pathways

Case Study

Patient-Reported Outcomes: Investing in Real-Time Intervention to Improve Care

04/16/2019

Diane Denny, DBA, MHA, FACHE, CPHQ, CPPS

Brandon Bosch, MPH

Morgan Hannaford, MA

Scott R Hartman, MS, PMP

Abstract: A geographically dispersed network of hospitals began the journey to integrate patient-reported outcome (PRO) data in the form of quality-of-life measurement into daily operations beginning in 2012, moving...

...

04/16/2019

Journal of Clinical Pathways

Research Reports

Community Oncologists` Perception and Acceptance of Biosimilars in Oncology

09/13/2018

Chadi Nabhan, MD, MBA, FACP

Yolaine Jeune-Smith, PhD

Amy Valley, PharmD

Bruce A Feinberg, DO

Abstract: Biosimilars are hypothesized to contribute to lowering health care costs by entering the market at a discounted price compared with their reference biologics. Until recently, only filgrastim biosimilars...

...

09/13/2018

Journal of Clinical Pathways

From the Field

A Novel Clinical Pathways Approach to Delivering Regional-Based Clinical Trials and Patient Care in a Hybrid Academic-Community-Based System

05/15/2018

Kathryn E Patronik, MHA

Edward S Kim, MD, FACP

Abstract: The health care landscape is becoming constantly more complex with new drug treatments and molecular testing. In order to achieve consistent, up-to-date patient care, clinical pathways are becoming...

...

05/15/2018

Journal of Clinical Pathways

Perspectives

Industry Consolidation Within Clinical Pathways

11/27/2017

Winston Wong, PharmD

Abstract: Express Scripts recently announced the purchase of eviCore, a leading medical benefits management firm, for $3.6 billion. The merger has the potential to be the first comprehensive care management offering....

...

11/27/2017

Journal of Clinical Pathways

Perspectives

Frameworks for Assessing the Value of Cancer Drugs: Purely an Academic Exercise?

08/02/2016

Joshua P Cohen, PhD

Abstract: As the cost of prescription drugs increases, payers and providers alike have attempted to determine the value of treatments for high-cost disease, including cancer. In this article, the authors discuss the...

...

08/02/2016

Journal of Clinical Pathways

From the Field

Facilitating Physician Adherence to Clinical Pathways Across a Multi-Site Oncology Practice Network

02/16/2016

Brian J Gebhardt, MD

Sushil Beriwal, MD

Dwight E Heron, MD, MBA, FACRO, FACR

Abstract: With so many new developments in the field on oncology, physicians have a difficult time staying abreast of new guidelines and recommendations for different disease states. Clinical pathways are an...

...

02/16/2016

Journal of Clinical Pathways

Research Reports

A Clinical Pathway to Reduce Time to Antibiotic Administration in Pediatric Cancer Patients With Fever and Potential Neutropenia

12/14/2015

Adam Lamble, MD

Thuan Nguyen MD, PhD

Susan Lindemulder, MD, MCR

David M. Spiro, MD, MPH

Suman Malempati, MD

Dawn Nolt, MD, MPH

Linda C. Stork, MD

Abstract: The authors developed a novel clinical pathway in the pediatric emergency department (PED) of Doernbecher Children’s Hospital, Oregon Health & Science University, that endorses administering...

...

12/14/2015

Journal of Clinical Pathways